PiroVue® Gastrocnemius Recession System

Equinus deformity has been associated with over 96% of biomechanically related foot and ankle pathologies.1

  • Gastrocnemius Aponeurosis Intra-Muscular Recession
    • Medial mini-open incision (2.5cm-3cm)
    • Gastroc intra-muscular recession cadaveric study (using alternative recession instrumentation) showed dorsiflexion improvment.2
    • Proximal intramuscular approach avoids the sural nerve3
  • Control & guided release
  • Versatile
    • Recession can be done on both gastrocnemius and soleus muscles as identified by Silfverskiold test2
  • Visualization of open procedure
  • Convenience of Sterile Pack Kit
    • No endoscopic equipment required
    • No ancillary draping time or associated costs
  1. Russel S. Hill. “Ankle equinus. Prevalence and linkage to common foot pathology.” Journal of the American Podiatric Medical Association. Jun;85(6):295-300. 1995.
  2. John E. Herzenburg, MD; Bradley M. Lamm, DPM; Chris Corwin, DPM; John Sekel, DPM. "Isolated Recession of the Gastrocnemius Muscle: The Baumann Proce­dure. " Foot & Ankle International. Vol. 28, No. 11. November 2007.
  3. Neal M. Blitz, DPM and Shannon M. Rush, DPM. " The Gastrocnemius Intramuscular Aponeurotic Recession: A Simplified Method of Gastrocnemius Recession." The Journal of Foot & Ankle Surgery. Vol. 46 Number 2 March/April 2007.


PiroVue® is a trademark of Nextremity Solutions, Inc.

Nextremity Solutions is the Legal Manufacturer of the PiroVue Gastrocnemius Recession System and Zimmer Biomet is the exclusive distributor.

All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.  
This material is intended for health care professionals. Distribution to any other recipient is prohibited.
For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the package insert and information on this website. To obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please call 1-800-348-2759, press 4 for 411 Technical Support.